Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Preclinical costs reduced by new human cell culture system from Northern Germany

02.06.2006
The young biotech start up company PRIMACYT has developed a long-term human hepatocyte culture system that may be used as a biosensor for the analysis of drugs, food additives, and chemicals. The entrepreneur team has developed serum-free long-term culture techniques for hepatocytes. Currently, several other companies are validating this culture technique in a multi-center study. The technology is presented on international conferences in San Francisco, USA April 2006 and Linz, Austria June 2006.

The PRIMACYT Cell Culture Technology GmbH has developed serum-free long-term culture techniques for hepatocytes. These technologies allow utilization of human and other mammalian hepatocytes as biosensors for screening purposes, while the hepatocyte specific functions remain intact. On this basis, new innovative products and services will be created to provide pharmaceutical and biotech companies as well as public research institutions with state of the art solutions for their specific demands.


Mikroskopische Aufnahme einer humanen Leberzelle, Primacyt GmbH

The major advantages of this hepatocyte culture system are its robustness and the fact that the hepatocytes remain differentiated and functional for several weeks. Preliminary studies have revealed that repetitive cycles of drug administrations can be applied to the cells. In other words, the hepatocytes may not only be used for one experiment, but instead can be "recycled" and may be used for a second, a third or even a fourth round of experiments. Thereby, the system is designed to reduce the number of animal experiments and to reduce the costs of preclinical studies.

The company is presenting its human hepatocyte culture system HEPAC2 at the annual Experimental Biology meeting in San Francisco, April 1-5, and at the 13th Conference on Alternatives to Animal Testing in Linz, Austria, on June 2-4. "These are a great opportunities for our company to demonstrate the advantages of our culture system to a broad audience" said Dr. Dieter Runge, co-founder and CEO of this young biotech company.

PRIMACYT Cell Culture Technology GmbH has its roots in HeparCell GmbH, originally founded by 4 private individuals in June 2004. In December 2004 HeparCell completed a private financing round led by Genius Venture Capital GmbH. In January 2005 HeparCell started its business at the Technologie- und Gewerbezentrum Schwerin. In October 2005 HeparCell GmbH changed its corporate name to PRIMACYT Cell Culture Technology. PRIMACYT is member of BioCon Valley.

BioCon Valley is the initiative for Life Science and health economy of Mecklenburg-Vorpommern, Germany. As one of the German BioRegions BioCon Valley supports the commercial use of modern life sciences and bio- and medical technologies in the region. BioCon Valley s tasks are networking, managing life science centers (bioincubators), project management and coordination, and life science specific public relation. BioCon Valley collaborates in strategic partnership to the life science initiatives at the Baltic Sea (www.scanbalt.org).

Contact:
PRIMACYT Cell Culture Technology GmbH
Dr. Dieter Runge
Hagenower Straße 73
19061 Schwerin
Germany
Telefon: +49 (0)385 - 3993 600
Telefax: +49 (0)385 - 3993 602
E-mail: info@primacyt.de

Dr. Heinrich Cuypers | idw
Further information:
http://www.primacyt.de
http://www.bcv.org

More articles from Life Sciences:

nachricht Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery
20.01.2017 | GSI Helmholtzzentrum für Schwerionenforschung GmbH

nachricht Seeking structure with metagenome sequences
20.01.2017 | DOE/Joint Genome Institute

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Traffic jam in empty space

New success for Konstanz physicists in studying the quantum vacuum

An important step towards a completely new experimental access to quantum physics has been made at University of Konstanz. The team of scientists headed by...

Im Focus: How gut bacteria can make us ill

HZI researchers decipher infection mechanisms of Yersinia and immune responses of the host

Yersiniae cause severe intestinal infections. Studies using Yersinia pseudotuberculosis as a model organism aim to elucidate the infection mechanisms of these...

Im Focus: Interfacial Superconductivity: Magnetic and superconducting order revealed simultaneously

Researchers from the University of Hamburg in Germany, in collaboration with colleagues from the University of Aarhus in Denmark, have synthesized a new superconducting material by growing a few layers of an antiferromagnetic transition-metal chalcogenide on a bismuth-based topological insulator, both being non-superconducting materials.

While superconductivity and magnetism are generally believed to be mutually exclusive, surprisingly, in this new material, superconducting correlations...

Im Focus: Studying fundamental particles in materials

Laser-driving of semimetals allows creating novel quasiparticle states within condensed matter systems and switching between different states on ultrafast time scales

Studying properties of fundamental particles in condensed matter systems is a promising approach to quantum field theory. Quasiparticles offer the opportunity...

Im Focus: Designing Architecture with Solar Building Envelopes

Among the general public, solar thermal energy is currently associated with dark blue, rectangular collectors on building roofs. Technologies are needed for aesthetically high quality architecture which offer the architect more room for manoeuvre when it comes to low- and plus-energy buildings. With the “ArKol” project, researchers at Fraunhofer ISE together with partners are currently developing two façade collectors for solar thermal energy generation, which permit a high degree of design flexibility: a strip collector for opaque façade sections and a solar thermal blind for transparent sections. The current state of the two developments will be presented at the BAU 2017 trade fair.

As part of the “ArKol – development of architecturally highly integrated façade collectors with heat pipes” project, Fraunhofer ISE together with its partners...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Sustainable Water use in Agriculture in Eastern Europe and Central Asia

19.01.2017 | Event News

12V, 48V, high-voltage – trends in E/E automotive architecture

10.01.2017 | Event News

2nd Conference on Non-Textual Information on 10 and 11 May 2017 in Hannover

09.01.2017 | Event News

 
Latest News

Helmholtz International Fellow Award for Sarah Amalia Teichmann

20.01.2017 | Awards Funding

An innovative high-performance material: biofibers made from green lacewing silk

20.01.2017 | Materials Sciences

Ion treatments for cardiac arrhythmia — Non-invasive alternative to catheter-based surgery

20.01.2017 | Life Sciences

VideoLinks
B2B-VideoLinks
More VideoLinks >>>